Loading clinical trials...
Loading clinical trials...
INFLAMA : Histological and Molecular Characterization of Capsule Inflammation in Patients Exposed to Silicone Breast Implants
Conditions
Interventions
analysis of samples of periprosthetic capsules taken during breast implant change procedure
Locations
1
France
CHU de Besançon
Besançon, France
Start Date
May 3, 2024
Primary Completion Date
May 31, 2025
Completion Date
May 31, 2025
Last Updated
May 16, 2024
NCT05190978
NCT05899387
NCT04783818
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions